Faculty Affiliation

Maria Zhu, MSc
Department of Psychiatry, University of British Columbia, Vancouver, Canada

Ran Ha Hong, BSc
Department of Psychiatry, University of British Columbia, Vancouver, Canada

Tao Yang, MD, PhD
Shanghai Mental Health Center and Shanghai Jiao Tong University School of Medicine, Shanghai, China

Xiaorui Yang, MD
Shanghai Mental Health Center and Shanghai Jiao Tong University School of Medicine, Shanghai, China

Xing Wang, MD
Shanghai Mental Health Center and Shanghai Jiao Tong University School of Medicine, Shanghai, China

Jing Liu, MHA
Department of Psychiatry, University of British Columbia, Vancouver, Canada

Jill K. Murphy, PhD
Department of Psychiatry, University of British Columbia, Vancouver, Canada

Erin E. Michalak, PhD
Department of Psychiatry, University of British Columbia, Vancouver, Canada

Zuowei Wang, MD, PhD
Hongkou Mental Health Center, Shanghai, China

Lakshmi N. Yatham, MBBS, MBA(Exec)
Department of Psychiatry, University of British Columbia, Vancouver, Canada

Jun Chen, MD, PhD
Shanghai Mental Health Center and Shanghai Jiao Tong University School of Medicine, Shanghai, China

Raymond W. Lam, MD*
Department of Psychiatry, University of British Columbia, Vancouver, Canada

*Corresponding authors: Raymond W. Lam, MD, 2255 Wesbrook Mall, Vancouver, BC, Canada V6T 2A1 (r.lam@ubc.ca).

Financial Disclosure

All individuals in a position to influence the content of this activity were asked to complete a statement regarding all relevant personal financial relationships between themselves or their spouse/partner and any commercial interest. The CME Institute has resolved any conflicts of interest that were identified. In the past 3 years, Marlene P. Freeman, MD, Editor in Chief of The Journal of Clinical Psychiatry, has received research funding from JayMac and Sage; has been a member of the Independent Data Safety and Monitoring Committee for Janssen (Johnson & Johnson) and Novartis; and has served on advisory boards for Eliem and Sage. As an employee of Massachusetts General Hospital (MGH), Dr Freeman works with the MGH National Pregnancy Registry, which receives funding from Alkermes, Aurobindo, AuroMedics, Johnson & Johnson/Janssen, Otsuka, Sage, Sunovion, Supernus, and Teva, and works with the MGH Clinical Trials Network and Institute, which receives research funding from multiple pharmaceutical companies and the National Institute of Mental Health. No member of the CME Institute staff reported any relevant personal financial relationships.

Dr Michalak has received funding to support patient education initiatives from Otsuka. Dr Yatham has been on speaker/advisory boards for, or has received research grants from Alkermes, AstraZeneca, Bristol-Myers Squibb, the Canadian Network for Mood and Anxiety Treatments (CANMAT), the Canadian Institutes of Health Research (CIHR), Sumitomo Dainippon Pharma (DSP), Eli Lilly, GlaxoSmithKline, Janssen, the Michael Smith Foundation for Health Research, Pfizer, Servier, Sunovion, and the Stanley Foundation. Dr Chen has received honoraria for ad hoc speaking for DSP, Eli Lilly, Pfizer, Lundbeck, Janssen, and Sunovion. Dr Lam has received honoraria for ad hoc speaking or advising/consulting, or received research funds, from Allergan, Asia-Pacific Economic Cooperation, BC Leading Edge Foundation, CIHR, CANMAT, Healthy Minds Canada, Janssen, Lundbeck, Lundbeck Institute, Michael Smith Foundation for Health Research, Mitacs, Myriad Neuroscience, Ontario Brain Institute, Otsuka, Pfizer, Unity Health, and VGH-UBC Hospital Foundation. Ms Zhu, Ms Hong, Ms Liu, Dr T. Yang, Dr X. Yang, Dr Murphy, and Z. Wang have no disclosures.